Invitation to Capio’s capital market day in Stockholm on March 15, 2016
Capio AB (publ) invites investors, financial analysts and media to the Group’s capital market day on March 15, 2016 at Capio St. Göran’s hospital (auditorium) in Stockholm, Sweden.
During the capital market day presentations about the Capio strategy and business operations will be given by Thomas Berglund, president and CEO, and other members of Capio’s Group Management. The program will also include presentations of the strategy in action in some of the Group’s largest business areas as well as a walk through Capio St. Göran’s hospital.
To participate, please register at www.capio.com/en/investors/capital-market-day-2016/. A detailed agenda will be sent to participants well in advance of March 15.
We look forward to your participation.
For information, please contact:
Proposed changes in composition of the Board of Directors of Novo Nordisk A/S
The Annual General Meeting of Novo Nordisk A/S is planned to be held on Friday 18 March 2016.
All board members elected by the Annual General Meeting are up for election. Thomas Paul Koestler and Eivind Kolding do not seek re-election.
At the Annual General Meeting, the Board of Directors proposes re-election of the following board members elected by the shareholders: Göran Ando (chairman), Jeppe Christiansen (vice chairman), Bruno Angelici, Sylvie Grégoire, Liz Hewitt and Mary Szela.
Furthermore, the Board of Directors proposes that Brian Daniels is elected as new member to the Board of Directors.
Brian Daniels, MD, is a senior advisor with the Boston Consulting Group and venture partner with 5AM Venture Management, LLC, both in the US. The Board of Directors recommends election of Brian Daniels because of his extensive experience in clinical development, medical affairs and corporate strategy across a broad range of therapeutics areas within the pharmaceutical industry, especially in the US.
Baxter Declares Quarterly Dividend
Baxter International Inc. (NYSE:BAX) today declared a regular quarterly dividend of $0.115 per Baxter common share. This cash dividend is payable on April 1, 2016 to shareholders of record as of March 4, 2016. read more